CTOR
Financials
- Market Capitalization 72.53 M
- Employee N/A
- Founded 2021
- CEO N/A
- Website www.citiusonc.com
- Headquarter Delaware, United States
- FIGI BBG01163HKY3
- Industry Drug Manufacturers—Specialty & Generic
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3838 |  CPIX Cumberland Pharmaceuticals Inc. - Common Stock | 8.46 USD | -2.20% | +10.30% | +27.99% | +151.79% | 126.76 M USD | ||
| 4044 |  ZYBT Zhengye Biotechnology Holding Limited - Class A Ordinary Shares | 1.73 USD | -1.70% | -13.50% | +45.38% | -29.10% | 81.99 M USD | ||
| 4169 |  BGM BGM Group Ltd. - Class A Ordinary Shares | 0.33 USD | +13.79% | +32.00% | +13.79% | -69.16% | 66.21 M USD | ||
| 4176 |  INCR Intercure Ltd. - ordinary shares | 5.78 USD | +1.76% | +6.25% | +508.42% | +265.82% | 63.21 M USD |
Frequently asked questions about Citius Oncology, Inc. Common Stock
What is the Citius Oncology, Inc. Common Stock stock price today?
The current price of Citius Oncology, Inc. Common Stock (CTOR) is 0.78. Over the past 24 hours, the stock has changed by -1.27%. Follow the CTOR chart for real-time price dynamics.
What is the stock ticker of Citius Oncology, Inc. Common Stock?
Citius Oncology, Inc. Common Stock trades under the ticker CTOR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Citius Oncology, Inc. Common Stock stock going up?
CTOR has changed by +2.63% over the last week, +50.00% over the last month, and -32.76% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Citius Oncology, Inc. Common Stock?
Citius Oncology, Inc. Common Stock currently has a market capitalization of 72.53 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Citius Oncology, Inc. Common Stock earnings last quarter?
Last quarter, Citius Oncology, Inc. Common Stock reported earnings of -0.08 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Citius Oncology, Inc. Common Stock revenue for the last quarter?
Citius Oncology, Inc. Common Stock reported quarterly revenue of 1.49 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Citius Oncology, Inc. Common Stock net income for the last quarter?
Citius Oncology, Inc. Common Stock reported net income of -8.92 M for the last quarter. The previous quarter showed -26.61 M, which means net income changed by +66.46%.
What is Citius Oncology, Inc. Common Stock EBITDA?
Citius Oncology, Inc. Common Stock EBITDA is -8.54 M, and its EBITDA margin is -571.52%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Citius Oncology, Inc. Common Stock stock?
You can buy Citius Oncology, Inc. Common Stock (CTOR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Citius Oncology, Inc. Common Stock stock?
Investing in Citius Oncology, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the CTOR chart and related analysis on metatrader.com as part of your research.